Development and Validation of a Nomogram to Predict Minimal Symptom Expression in AChR+ gMG Patients Undergoing Efgartigimod Therapy.

Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio

http://www.ncbi.nlm.nih.gov/pubmed/42634333

Benqiao Wang; Chi Ma; Jingyi Shen; Nan Kang; Ruixia Zhu; Tianying Ma; Ying Zhu

Aug 25, 2026